Workflow
瑞银:升药明康德目标价至82.5港元 评级“买入”
news flash·2025-04-29 02:52

Core Viewpoint - UBS has raised the target price for WuXi AppTec to HKD 82.5 and maintains a "Buy" rating based on the company's strong Q1 performance and consistent guidance for the year [1] Financial Performance - WuXi AppTec's Q1 performance exceeded expectations, with the company maintaining its revenue guidance for the year, projecting a year-on-year growth of 10% to 15%, amounting to RMB 41.5 billion to RMB 43 billion [1] - The company has set its capital expenditure target at RMB 7 billion to RMB 8 billion and free cash flow at RMB 4 billion to RMB 5 billion [1] Earnings Forecast - UBS has slightly adjusted its earnings model, lowering the earnings per share (EPS) forecast for this year from RMB 4.15 to RMB 4.12, while maintaining the EPS forecast for next year at RMB 4.71 [1] - The EPS forecast for 2027 has been slightly increased from RMB 5.37 to RMB 5.38 [1]